2018
DOI: 10.1016/j.jtho.2018.08.2026
|View full text |Cite
|
Sign up to set email alerts
|

Impact of Lymph Node Dissection on Thymic Malignancies: Multi-Institutional Propensity Score Matched Analysis

Abstract: Lymph node metastasis was a significant prognostic factor in thymic malignancies. Although LND did not improve long-term outcomes in thymic malignancies, LND played a role in accurate staging, and improved prediction of prognosis.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

6
32
5

Year Published

2019
2019
2024
2024

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 30 publications
(43 citation statements)
references
References 22 publications
6
32
5
Order By: Relevance
“…We thank Yu et al for their interest in our study and questions. 1 They argued the high rate of lymph node metastasis in thymoma, with an incidence of 6.7% in our study. In their experience, Yu et al 1 could not find any metastasis in any of 417 patients with thymoma.…”
Section: To the Editorsupporting
confidence: 48%
See 2 more Smart Citations
“…We thank Yu et al for their interest in our study and questions. 1 They argued the high rate of lymph node metastasis in thymoma, with an incidence of 6.7% in our study. In their experience, Yu et al 1 could not find any metastasis in any of 417 patients with thymoma.…”
Section: To the Editorsupporting
confidence: 48%
“…6,7 Meanwhile, there were some studies that catered to the recommendation and began claiming that the rates of lymphogenous metastasis in thymoma were 1.2% to 2.3%. 8,9 But in the latest article of Hwang et al, 1 the rate reached up to 6.7%. Which factor could have led to such a "marked shift"?…”
Section: The Real Situation Of Lymph Node Metastases In Thymomamentioning
confidence: 96%
See 1 more Smart Citation
“…The actual incidence of lymph node metastasis has not been well established. Historically, the prevalence of lymph nodes involvement has been described ranging from 1.8% to 5.1% in thymomas and from 20% to 33.5% in thymic carcinomas and NETs, but these rates could be underestimated because lymphadenectomy is rarely performed by most institutions [91][92][93][94][95] . Two factors have been described to explain lymph node metastasis, namely WHO subtype and tumor size, being both closely related to the biologic aggressiveness of the tumor [96,97] .…”
Section: Lymphadenectomymentioning
confidence: 99%
“…To the Editor: Much-needed consensus recommendations on the use of radiation therapy for malignant pleural mesothelioma (MPM) were recently provided by an expert panel. 1 The authors focused their efforts to standardize/optimize radical treatments, with adjuvant radiotherapy delivered before or after extrapleural pneumonectomy or after pleurectomy/decortication. However, new studies are opening the way to reconsider a more aggressive approach in the palliative setting in view of preliminary evidence on increasing patients' overall survival.…”
Section: The "Radical" Palliation That Increases Survival In Malignanmentioning
confidence: 99%